Patient Assistance Programs, Medications for MPN Patients
by David Wallace
PV Reporter is very proud to announce a new partnership with the PAN Foundation. Myeloproliferative Neoplasm (MPN) patients may be eligible for $8,500 per year (or more if a 2nd grant is needed/approved) in assistance assuming you meet the eligibility criteria which are very reasonable.
The status is presently open and you can apply online or call 1-866-316-7263. Their coverage for MPN patients is very comprehensive. A few of the drugs include:
- Jakafi
- Pegasys (peginterferon alfa-2a)
- Hydrea
- Intron A (interferon alfa-2b)
- Anagrelide Hcl
- Prednisone
- Busulfun
- Danazol
Please check out the PAN Foundation website for a complete list.
The Patient Access Network (PAN) Foundation is an independent, national 501 (c)(3) organization dedicated to helping federally and commercially insured people living with life-threatening, chronic and rare diseases with the out-of-pocket costs for their prescribed medications. Since its founding in 2004, PAN has provided nearly 1 million under insured patients with over $3 billion in financial assistance, through close to 70 disease-specific programs.
